LNX2 and diffuse large B-cell lymphoma: Furthermore, a GWAS identified a single nucleotide polymorphism (SNP) within the LNX2 promoter region that was linked to increased susceptibility to diffuse large B-cell lymphoma [76] and another GWAS linked a SNP in the LNX2 gene to differential responses to the chemotherapeutic drug cytosine arabinoside in lymphoblastoid cells [43].